Kuwae T et al. |
Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. |
1999 |
FEBS Lett. |
pmid:10508930
|
Melck D et al. |
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. |
1999 |
FEBS Lett. |
pmid:10606728
|
Maurelli S et al. |
Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. |
1995 |
FEBS Lett. |
pmid:8543025
|
Flygare J et al. |
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. |
2005 |
FEBS Lett. |
pmid:16337199
|
Nakajima Y et al. |
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. |
2006 |
FEBS Lett. |
pmid:16406050
|
Fowler CJ |
Transport of endocannabinoids across the plasma membrane and within the cell. |
2013 |
FEBS J. |
pmid:23441874
|
Stark K et al. |
Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. |
2008 |
FEBS J. |
pmid:18549450
|
van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
Mascolo N et al. |
The endocannabinoid system and the molecular basis of paralytic ileus in mice. |
2002 |
FASEB J. |
pmid:12397089
|
Varga K et al. |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. |
1998 |
FASEB J. |
pmid:9707176
|
Bátkai S et al. |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
2007 |
FASEB J. |
pmid:17327359
|
Karwad MA et al. |
The role of CB in intestinal permeability and inflammation. |
2017 |
FASEB J. |
pmid:28404744
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Bifulco M et al. |
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. |
2001 |
FASEB J. |
pmid:11687506
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Jones S and Howl J |
Cannabinoid receptor systems: therapeutic targets for tumour intervention. |
2003 |
Expert Opin. Ther. Targets |
pmid:14640910
|
Lory P and Chemin J |
Towards the discovery of novel T-type calcium channel blockers. |
2007 |
Expert Opin. Ther. Targets |
pmid:17465728
|
Bambico FR and Gobbi G |
The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. |
2008 |
Expert Opin. Ther. Targets |
pmid:18851692
|
Wise ML et al. |
Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. |
1996 |
Experientia |
pmid:8575565
|
Feizi A et al. |
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. |
2008 |
Exp. Toxicol. Pathol. |
pmid:18571910
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Hansen HS |
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. |
2010 |
Exp. Neurol. |
pmid:20353771
|
Greco R et al. |
The endocannabinoid system and migraine. |
2010 |
Exp. Neurol. |
pmid:20353780
|
Bhaskaran MD and Smith BN |
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. |
2010 |
Exp. Neurol. |
pmid:20144892
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Solbrig MV et al. |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. |
2005 |
Exp. Neurol. |
pmid:16022863
|
Morgese MG et al. |
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. |
2007 |
Exp. Neurol. |
pmid:17900568
|
Köse S et al. |
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. |
2018 |
Exp. Hematol. |
pmid:29030083
|
Matsuda S et al. |
Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. |
1997 |
Exp. Eye Res. |
pmid:9245900
|
Jumpertz R et al. |
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide. |
2010 |
Exp. Clin. Endocrinol. Diabetes |
pmid:20429051
|
De Petrocellis L et al. |
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. |
2007 |
Exp. Cell Res. |
pmid:17428469
|
Frampton G et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. |
2010 |
Exp. Cell Res. |
pmid:20347808
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Prestifilippo JP et al. |
Inhibition of salivary secretion by activation of cannabinoid receptors. |
2006 |
Exp. Biol. Med. (Maywood) |
pmid:16946411
|
Wiley JL et al. |
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. |
2004 |
Exp Clin Psychopharmacol |
pmid:15301634
|
Burkey RT and Nation JR |
(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. |
1997 |
Exp Clin Psychopharmacol |
pmid:9260067
|
Gratzke C et al. |
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147270
|
Prieto D |
Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147273
|
Peroni RN et al. |
Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. |
2004 |
Eur. J. Pharmacol. |
pmid:15189776
|
Chen N et al. |
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. |
2003 |
Eur. J. Pharmacol. |
pmid:14575792
|
Beltramo M and Piomelli D |
Anandamide transport inhibition by the vanilloid agonist olvanil. |
1999 |
Eur. J. Pharmacol. |
pmid:9920187
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Vann RE et al. |
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. |
2009 |
Eur. J. Pharmacol. |
pmid:19470387
|
Ralevic V et al. |
Cannabinoid activation of recombinant and endogenous vanilloid receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11672565
|
Shi RZ et al. |
Decreased anandamide transporter activity and calcitonin gene-related peptide production in spontaneously hypertensive rats: role of angiotensin II. |
2012 |
Eur. J. Pharmacol. |
pmid:22318155
|
O'Sullivan SE et al. |
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. |
2005 |
Eur. J. Pharmacol. |
pmid:15659311
|
Del Arco I et al. |
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. |
2002 |
Eur. J. Pharmacol. |
pmid:12409011
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Wheal AJ et al. |
Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries. |
2012 |
Eur. J. Pharmacol. |
pmid:22154756
|
Bouaboula M et al. |
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. |
2005 |
Eur. J. Pharmacol. |
pmid:15987634
|
Nilsson O et al. |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells. |
2006 |
Eur. J. Pharmacol. |
pmid:16928371
|
Wiley JL et al. |
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. |
2014 |
Eur. J. Pharmacol. |
pmid:24858366
|
Mendizábal VE et al. |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. |
2001 |
Eur. J. Pharmacol. |
pmid:11567656
|
Shimasue K et al. |
Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. |
1996 |
Eur. J. Pharmacol. |
pmid:8904088
|
de Lago E et al. |
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. |
2004 |
Eur. J. Pharmacol. |
pmid:14744610
|
GarcÃa Mdel C et al. |
Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16472800
|
Moezi L et al. |
Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. |
2004 |
Eur. J. Pharmacol. |
pmid:14751408
|
Basavarajappa BS et al. |
Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. |
2003 |
Eur. J. Pharmacol. |
pmid:12679143
|
Guindon J et al. |
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? |
2006 |
Eur. J. Pharmacol. |
pmid:17027744
|
Bondarenko AI et al. |
Direct activation of Ca and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor. |
2017 |
Eur. J. Pharmacol. |
pmid:28327344
|
Jackson SN et al. |
Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. |
2008 |
Eur. J. Pharmacol. |
pmid:18242598
|
Baldassano S et al. |
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. |
2008 |
Eur. J. Pharmacol. |
pmid:18234188
|
Fride E and Mechoulam R |
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. |
1993 |
Eur. J. Pharmacol. |
pmid:8384116
|
Smid SD et al. |
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. |
2007 |
Eur. J. Pharmacol. |
pmid:17706636
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Romano MR and Lograno MD |
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle. |
2013 |
Eur. J. Pharmacol. |
pmid:23396229
|
Ho WS |
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase. |
2013 |
Eur. J. Pharmacol. |
pmid:23340220
|
Stamer WD et al. |
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. |
2001 |
Eur. J. Pharmacol. |
pmid:11730719
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Costa B and Colleoni M |
Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol. |
2000 |
Eur. J. Pharmacol. |
pmid:10781666
|
Varga K et al. |
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. |
1995 |
Eur. J. Pharmacol. |
pmid:7589169
|
Alptekin A et al. |
The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels. |
2010 |
Eur. J. Pharmacol. |
pmid:20171208
|
Randall MD et al. |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. |
1997 |
Eur. J. Pharmacol. |
pmid:9314035
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
López-Miranda V et al. |
Anandamide vehicles: a comparative study. |
2004 |
Eur. J. Pharmacol. |
pmid:15556148
|
Braida D et al. |
5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17116299
|
Castelli MP et al. |
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. |
2007 |
Eur. J. Pharmacol. |
pmid:17644084
|
Marichal-Cancino BA et al. |
Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats. |
2013 |
Eur. J. Pharmacol. |
pmid:24076186
|
Adinolfi B et al. |
Anticancer activity of anandamide in human cutaneous melanoma cells. |
2013 |
Eur. J. Pharmacol. |
pmid:24041928
|
Martin BR et al. |
Assessment of structural commonality between tetrahydrocannabinol and anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:11790376
|
Oz M et al. |
Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. |
2000 |
Eur. J. Pharmacol. |
pmid:10980258
|
Smart D et al. |
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. |
2001 |
Eur. J. Pharmacol. |
pmid:11301059
|
Dembiński A et al. |
Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. |
2008 |
Eur. J. Pharmacol. |
pmid:18593574
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Fride E et al. |
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. |
2001 |
Eur. J. Pharmacol. |
pmid:11426843
|
Someya A et al. |
Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. |
2002 |
Eur. J. Pharmacol. |
pmid:12206851
|
Sprague J et al. |
Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11448475
|
Di Marzo V et al. |
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. |
2001 |
Eur. J. Pharmacol. |
pmid:11408034
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Rácz I et al. |
Anandamide effects on 5-HT(3) receptors in vivo. |
2008 |
Eur. J. Pharmacol. |
pmid:18775693
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Haller VL et al. |
Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. |
2008 |
Eur. J. Pharmacol. |
pmid:18762181
|
Berdyshev EV et al. |
Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. |
1997 |
Eur. J. Pharmacol. |
pmid:9253958
|